City Bulletin: AstraZeneca sells rights to best-selling anti-cholesterol drug
AstraZeneca agrees $350m rights deal, Horta-Osório transfers to Credit Suisse, 2021 market predictions
AstraZeneca agrees $350m rights deal, Horta-Osório transfers to Credit Suisse, 2021 market predictions